References
- Alhariri M, Majrashi MA, Bahkali AH, Almajed FS, Azghani AO, Khiyami MA, Alyamani EJ, Aljohani SM, Halwani MA. Efficacy of neutral and negatively charged liposome-loaded gentamicin on planktonic bacteria and biofilm communities. Int J Nanomedicine. 2017. 12: 6949-6961. https://doi.org/10.2147/IJN.S141709
- Alimova IN, Liu B, Fan Z, Edgerton SM, Dillon T, Lind SE, Thor AD. Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle. 2009. 8: 909-915. https://doi.org/10.4161/cc.8.6.7933
- Allen TM, Cullis PR. Liposomal drug delivery systems: From concept to clinical applications. Adv Drug Deliv Rev. 2013. 65: 36-48. https://doi.org/10.1016/j.addr.2012.09.037
- Amann R, Peskar BA. Anti-inflammatory effects of aspirin and sodium salicylate. Eur J Pharmacol. 2002. 447: 1-9. https://doi.org/10.1016/S0014-2999(02)01828-9
- Bao B, Wang Z, Ali S, Ahmad A, Azmi AS, Sarkar SH, Banerjee S, Kong D, Li Y, Thakur S, Sarkar FH. Metformin inhibits cell proliferation, migration and invasion by attenuating csc function mediated by deregulating mirnas in pancreatic cancer cells. Cancer Prev Res. 2012. 5: 355-364. https://doi.org/10.1158/1940-6207.CAPR-11-0299
- Bellosillo B, Pique M, Barragan M, Castano E, Villamor N, Colomer D, Montserrat E, Pons G, Gil J. Aspirin and salicylate induce apoptosis and activation of caspases in b-cell chronic lymphocytic leukemia cells. Blood. 1998. 92: 1406-1414. https://doi.org/10.1182/blood.V92.4.1406
- Bowker SL, Majumdar SR, Veugelers P, Johnson JA. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care. 2006. 29: 254-258. https://doi.org/10.2337/diacare.29.02.06.dc05-1558
- De Jong WH, Borm PJA. Drug delivery and nanoparticles: Applications and hazards. International Journal of Nanomedicine. 2008. 3: 133-149. https://doi.org/10.2147/IJN.S596
- Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer. 2005. 5: 275-284. https://doi.org/10.1038/nrc1590
- Dikshit P, Chatterjee M, Goswami A, Mishra A, Jana NR. Aspirin induces apoptosis through the inhibition of proteasome function. J Biol Chem. 2006. 281: 29228-29235. https://doi.org/10.1074/jbc.M602629200
- Dowling RJ, Zakikhani M, Fantus IG, Pollak M, Sonenberg N. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res. 2007. 67: 10804-10812. https://doi.org/10.1158/0008-5472.CAN-07-2310
- Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD. Metformin and reduced risk of cancer in diabetic patients. Bmj. 2005. 330: 1304-1305. https://doi.org/10.1136/bmj.38415.708634.F7
- Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: Consistent evidence from randomised and observational studies. Lancet. 2007. 369: 1603-1613. https://doi.org/10.1016/S0140-6736(07)60747-8
- Gangemi R, Paleari L, Orengo AM, Cesario A, Chessa L, Ferrini S, Russo P. Cancer stem cells: A new paradigm for understanding tumor growth and progression and drug resistance. Curr Med Chem. 2009. 16: 1688-1703. https://doi.org/10.2174/092986709788186147
- Han JS, Crowe DL. Tumor initiating cancer stem cells from human breast cancer cell lines. Int J Oncol. 2009. 34: 1449-1453.
- Hirsch HA, Iliopoulos D, Struhl K. Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth. Proc Natl Acad Sci U S A. 2013. 110: 972-977. https://doi.org/10.1073/pnas.1221055110
- Jeong K, Kang CS, Kim Y, Lee YD, Kwon IC, Kim S. Development of highly efficient nanocarrier-mediated delivery approaches for cancer therapy. Cancer Lett. 2016. 374: 31-43. https://doi.org/10.1016/j.canlet.2016.01.050
- Ji P, Zhang Y, Wang SJ, Ge HL, Zhao GP, Xu YC, Wang Y. Cd44hicd24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs. Oncol Rep. 2016. 35: 3293-3302. https://doi.org/10.3892/or.2016.4739
- Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM, Hsu L, Hung MC, Hortobagyi GN, Gonzalez-Angulo AM. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol. 2009. 27: 3297-3302. https://doi.org/10.1200/JCO.2009.19.6410
- Lee EJ. Cancer chemoprevention effects of geldanamycin and 17-aag in human oral squamous cell carcinoma. Korean Journal of Clinical Laboratory Science. 2018. 50: 462-469. https://doi.org/10.15324/kjcls.2018.50.4.462
- Kai M, Kanaya N, Wu SV, Mendez C, Nguyen D, Luu T, Chen S. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of lbh589 and salinomycin. Breast Cancer Res Treat. 2015. 151: 281-294. https://doi.org/10.1007/s10549-015-3376-5
- Kim J-E, Kang B-I, Bae S-M, Han S, Jun A, Han J, Cho M-A, Choi Y-L, Lee J-H, Moon Y-H. An analytical validation of the geneswell tm bct multigene prognostic test in patients with early breast cancer. Korean Journal of Clinical Laboratory Science. 2017a. 49: 79-87. https://doi.org/10.15324/kjcls.2017.49.2.79
- Kim Y-J, Park H-B, Kim P-H, Park JS, Kim K-S. Enhanced anticancer efficacy in mcf-7 breast cancer cells by combined drugs of metformin and sodium salicylate. Biomedical Science Letters. 2017b. 23: 290-294. https://doi.org/10.15616/BSL.2017.23.3.290
- Klampfer L, Cammenga J, Wisniewski H-G, Nimer S. Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines. Blood. 1999. 93: 2386-2394. https://doi.org/10.1182/blood.V93.7.2386
- Law BK, Waltner-Law ME, Entingh AJ, Chytil A, Aakre ME, Norgaard P, Moses HL. Salicylate-induced growth arrest is associated with inhibition of p70s6k and down-regulation of c-myc, cyclin d1, cyclin a, and proliferating cell nuclear antigen. J Biol Chem. 2000. 275: 38261-38267. https://doi.org/10.1074/jbc.M005545200
- Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, Hilsenbeck SG, Pavlick A, Zhang X, Chamness GC, Wong H, Rosen J, Chang JC. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst. 2008. 100: 672-679. https://doi.org/10.1093/jnci/djn123
- Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, Evans JM. New users of metformin are at low risk of incident cancer: A cohort study among people with type 2 diabetes. Diabetes Care. 2009. 32: 1620-1625. https://doi.org/10.2337/dc08-2175
- Liu B, Fan Z, Edgerton SM, Deng XS, Alimova IN, Lind SE, Thor AD. Metformin induces unique biological and molecular responses in triple negative breast cancer cells. Cell Cycle. 2009. 8: 2031-2040. https://doi.org/10.4161/cc.8.13.8814
- Longley DB, Johnston PG. Molecular mechanisms of drug resistance. J Pathol. 2005. 205: 275-292. https://doi.org/10.1002/path.1706
- Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massague J. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest. 2005. 115: 44-55. https://doi.org/10.1172/JCI22320
- Mukherjee S, Mazumdar M, Chakraborty S, Manna A, Saha S, Khan P, Bhattacharjee P, Guha D, Adhikary A, Mukhjerjee S, Das T. Curcumin inhibits breast cancer stem cell migration by amplifying the e-cadherin/beta-catenin negative feedback loop. Stem Cell Res Ther. 2014. 5:116. https://doi.org/10.1186/scrt506
- Nag O, Yadav V, Hedrick A, Awasthi V. Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo. International Journal of Pharmaceutics. 2013. 446: 119-129. https://doi.org/10.1016/j.ijpharm.2013.02.026
- Song X, Ren Y, Zhang J, Wang G, Han X, Zheng W, Zhen L. Targeted delivery of doxorubicin to breast cancer cells by aptamer functionalized dotap/dope liposomes. Oncol Rep. 2015. 34: 1953-1960. https://doi.org/10.3892/or.2015.4136
- Ulrich CM, Bigler J, Potter JD. Non-steroidal anti-inflammatory drugs for cancer prevention: Promise, perils and pharmacogenetics. Nat Rev Cancer. 2006. 6: 130-140. https://doi.org/10.1038/nrc1801
- Vinogradov S, Wei X. Cancer stem cells and drug resistance: The potential of nanomedicine. Nanomedicine. 2012. 7: 597-615. https://doi.org/10.2217/nnm.12.22
- Zakikhani M, Dowling RJ, Sonenberg N, Pollak MN. The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of amp-activated protein kinase. Cancer Prev Res. 2008. 1: 369-375. https://doi.org/10.1158/1940-6207.CAPR-08-0081
- Zhang Z, Ni C, Chen W, Wu P, Wang Z, Yin J, Huang J, Qiu F. Expression of cxcr4 and breast cancer prognosis: A systematic review and meta-analysis. BMC Cancer. 2014. 14: 1471-2407.
- Zou Y, Priebe W, Perez-Soler R. Lyophilized preliposomal formulation of the non-cross-resistant anthracycline annamycin: Effect of surfactant on liposome formation, stability and size. Cancer Chemother Pharmacol. 1996. 39: 103-108. https://doi.org/10.1007/s002800050544